|
Video: What is a Stock Split?
|
|
Enlivex Therapeutics is a development stage biopharmaceutical company focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases. Co. seeks to identify therapeutic platforms that offer solutions for several diseases that share a common pathophysiological mechanism, which are the functional changes that accompany a particular syndrome or disease. Co.'s pipeline is based on three platforms, which are Protein Stabilizing Platform, Read-through Platform and Mitochondrial Protein Replacement Platform. According to our ORPN split history records, ORPN has had 2 splits. | |
|
ORPN (ORPN) has 2 splits in our ORPN split history database. The first split for ORPN took place on November 05, 2009. This was a 1 for 4 reverse split, meaning for each 4 shares of ORPN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 250 share position following the split. ORPN's second split took place on September 25, 2017. This was a 1 for 5 reverse split, meaning for each 5 shares of ORPN owned pre-split, the shareholder now owned 1 share. For example, a 250 share position pre-split, became a 50 share position following the split.
When a company such as ORPN conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ORPN split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ORPN shares, starting with a $10,000 purchase of ORPN, presented on a split-history-adjusted basis factoring in the complete ORPN split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
07/31/2014 |
|
End date: |
03/25/2019 |
|
Start price/share: |
$42.00 |
|
End price/share: |
$11.50 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-72.62% |
|
Average Annual Total Return: |
-24.30% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2,738.72 |
|
Years: |
4.65 |
|
|
|
Date |
Ratio |
11/05/2009 | 1 for 4 | 09/25/2017 | 1 for 5 |
|
|